These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 28656662)
21. Testosterone, dihydrotestosterone, and incident cardiovascular disease and mortality in the cardiovascular health study. Shores MM; Biggs ML; Arnold AM; Smith NL; Longstreth WT; Kizer JR; Hirsch CH; Cappola AR; Matsumoto AM J Clin Endocrinol Metab; 2014 Jun; 99(6):2061-8. PubMed ID: 24628549 [TBL] [Abstract][Full Text] [Related]
22. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone. Anderson RA; Wallace AM; Wu FC J Clin Endocrinol Metab; 1996 Mar; 81(3):902-8. PubMed ID: 8772548 [TBL] [Abstract][Full Text] [Related]
23. Enhanced transdermal delivery of testosterone across nonscrotal skin produces physiological concentrations of testosterone and its metabolites in hypogonadal men. Meikle AW; Mazer NA; Moellmer JF; Stringham JD; Tolman KG; Sanders SW; Odell WD J Clin Endocrinol Metab; 1992 Mar; 74(3):623-8. PubMed ID: 1740497 [TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics and metabolism of a permeation-enhanced testosterone transdermal system in hypogonadal men: influence of application site- -a clinical research center study. Meikle AW; Arver S; Dobs AS; Sanders SW; Rajaram L; Mazer NA J Clin Endocrinol Metab; 1996 May; 81(5):1832-40. PubMed ID: 8626843 [TBL] [Abstract][Full Text] [Related]
25. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features. Daan NM; Jaspers L; Koster MP; Broekmans FJ; de Rijke YB; Franco OH; Laven JS; Kavousi M; Fauser BC Hum Reprod; 2015 Oct; 30(10):2376-86. PubMed ID: 26269538 [TBL] [Abstract][Full Text] [Related]
26. Serum testosterone, dihydrotestosterone and estradiol concentrations in older men self-reporting very good health: the healthy man study. Sartorius G; Spasevska S; Idan A; Turner L; Forbes E; Zamojska A; Allan CA; Ly LP; Conway AJ; McLachlan RI; Handelsman DJ Clin Endocrinol (Oxf); 2012 Nov; 77(5):755-63. PubMed ID: 22563890 [TBL] [Abstract][Full Text] [Related]
27. Endogenous sex hormones and cardiovascular disease incidence in men. Arnlöv J; Pencina MJ; Amin S; Nam BH; Benjamin EJ; Murabito JM; Wang TJ; Knapp PE; D'Agostino RB; Bhasin S; Vasan RS Ann Intern Med; 2006 Aug; 145(3):176-84. PubMed ID: 16880459 [TBL] [Abstract][Full Text] [Related]
28. High circulating oestrone and low testosterone correlate with adverse clinical outcomes in men with advanced liver disease. Sinclair M; Gow PJ; Angus PW; Hoermann R; Handelsman DJ; Wittert G; Martin S; Grossmann M Liver Int; 2016 Nov; 36(11):1619-1627. PubMed ID: 26998685 [TBL] [Abstract][Full Text] [Related]
29. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology. Labrie F; Bélanger A; Cusan L; Candas B J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308 [TBL] [Abstract][Full Text] [Related]
30. The Association of Reproductive Hormone Levels and All-Cause, Cancer, and Cardiovascular Disease Mortality in Men. Holmboe SA; Vradi E; Jensen TK; Linneberg A; Husemoen LL; Scheike T; Skakkebæk NE; Juul A; Andersson AM J Clin Endocrinol Metab; 2015 Dec; 100(12):4472-80. PubMed ID: 26488309 [TBL] [Abstract][Full Text] [Related]
31. Serum androgen bioactivity during 5alpha-dihydrotestosterone treatment in elderly men. Raivio T; Tapanainen JS; Kunelius P; Jänne OA J Androl; 2002; 23(6):919-21. PubMed ID: 12399539 [TBL] [Abstract][Full Text] [Related]
32. Impact level of dihydrotestosterone on the hypothalamic-pituitary-leydig cell axis in men. Cailleux-Bounacer A; Rohmer V; Lahlou N; Lefebvre H; Roger M; Kuhn JM Int J Androl; 2009 Feb; 32(1):57-65. PubMed ID: 17931384 [TBL] [Abstract][Full Text] [Related]
33. Longitudinal relationships of circulating reproductive hormone with functional disability, muscle mass, and strength in community-dwelling older men: the Concord Health and Ageing in Men project. Hsu B; Cumming RG; Naganathan V; Blyth FM; Le Couteur DG; Seibel MJ; Waite LM; Handelsman DJ J Clin Endocrinol Metab; 2014 Sep; 99(9):3310-8. PubMed ID: 24628559 [TBL] [Abstract][Full Text] [Related]
34. Higher serum undercarboxylated osteocalcin and other bone turnover markers are associated with reduced diabetes risk and lower estradiol concentrations in older men. Yeap BB; Alfonso H; Chubb SA; Gauci R; Byrnes E; Beilby JP; Ebeling PR; Handelsman DJ; Allan CA; Grossmann M; Norman PE; Flicker L J Clin Endocrinol Metab; 2015 Jan; 100(1):63-71. PubMed ID: 25365314 [TBL] [Abstract][Full Text] [Related]
35. Metabolism of sex steroids is influenced by acquired adiposity-A study of young adult male monozygotic twin pairs. Vihma V; Naukkarinen J; Turpeinen U; Hämäläinen E; Kaprio J; Rissanen A; Heinonen S; Hakkarainen A; Lundbom J; Lundbom N; Mikkola TS; Tikkanen MJ; Pietiläinen KH J Steroid Biochem Mol Biol; 2017 Sep; 172():98-105. PubMed ID: 28619249 [TBL] [Abstract][Full Text] [Related]
36. Age-specific population centiles for androgen status in men. Handelsman DJ; Yeap B; Flicker L; Martin S; Wittert GA; Ly LP Eur J Endocrinol; 2015 Dec; 173(6):809-17. PubMed ID: 26385186 [TBL] [Abstract][Full Text] [Related]
37. Lower Circulating Androgens Are Associated with Overall Cancer Risk and Prostate Cancer Risk in Men Aged 25-84 Years from the Busselton Health Study. Chan YX; Knuiman MW; Divitini ML; Handelsman DJ; Beilby JP; Yeap BB Horm Cancer; 2018 Dec; 9(6):391-398. PubMed ID: 30097782 [TBL] [Abstract][Full Text] [Related]
38. Comparative pharmacokinetics of three doses of percutaneous dihydrotestosterone gel in healthy elderly men--a clinical research center study. Wang C; Iranmanesh A; Berman N; McDonald V; Steiner B; Ziel F; Faulkner SM; Dudley RE; Veldhuis JD; Swerdloff RS J Clin Endocrinol Metab; 1998 Aug; 83(8):2749-57. PubMed ID: 9709942 [TBL] [Abstract][Full Text] [Related]
39. Androgens and glucuronidated androgen metabolites are associated with metabolic risk factors in men. Vandenput L; Mellström D; Lorentzon M; Swanson C; Karlsson MK; Brandberg J; Lönn L; Orwoll E; Smith U; Labrie F; Ljunggren O; Tivesten A; Ohlsson C J Clin Endocrinol Metab; 2007 Nov; 92(11):4130-7. PubMed ID: 17711928 [TBL] [Abstract][Full Text] [Related]